Oral melatonin as a new tool for neuroprotection in preterm newborns: study protocol for a randomized controlled trial

BACKGROUND: Prevention of neurodevelopmental impairment due to preterm birth is a major health challenge. Despite advanced obstetric and neonatal care, to date there are few neuroprotective molecules available. Melatonin has been shown to have anti-oxidant/anti-inflammatory effects and to reduce bra...

Descripción completa

Detalles Bibliográficos
Autores principales: Garofoli, Francesca, Longo, Stefania, Pisoni, Camilla, Accorsi, Patrizia, Angelini, Micol, Aversa, Salvatore, Caporali, Camilla, Cociglio, Sara, De Silvestri, Annalisa, Fazzi, Elisa, Rizzo, Vittoria, Tzialla, Chryssoula, Zecca, Marco, Orcesi, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820522/
https://www.ncbi.nlm.nih.gov/pubmed/33482894
http://dx.doi.org/10.1186/s13063-021-05034-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820522/
https://www.ncbi.nlm.nih.gov/pubmed/33482894
http://dx.doi.org/10.1186/s13063-021-05034-w

Ejemplares similares